India Pharma Outlook Team | Wednesday, 13 March 2024
Involution Healthcare is pleased to announce the virtual inauguration of its state-of-the-art Stent Manufacturing Facility in Jaipur.
The Production Linked Incentive (PLI) scheme made this momentous occasion possible. Esteemed dignitaries, including Dr. Mansukh Mandaviya, Hon'ble Union Minister of Chemicals & Fertilizers, and other high-ranking officials from the government and industry graced it.
This significant milestone marks a proud moment for Involution Healthcare, signifying our unwavering commitment to contributing to the government's vision of achieving self-reliance in the Medtech sector.
The Jaipur Stent Manufacturing Facility represents a strategic step towards advancing medical technology and ensuring accessibility to high-quality Medtech solutions.
During the event, Mr. Ashvini Suthar, Director and Co-Founder of Involution Healthcare, expressed his enthusiasm about the facility's inauguration, stating, "We are thrilled to witness the culmination of our efforts in establishing the Jaipur Stent Manufacturing Facility.
This venture aligns seamlessly with our commitment to supporting the government's vision of self-reliance in the healthcare sector. Our state-of-the-art facility is equipped to meet the growing demands of the industry, and we are confident that it will contribute significantly to the advancement of healthcare in India."
Involution Healthcare remains dedicated to innovation, excellence, and making meaningful contributions to the healthcare landscape. We thank all stakeholders, government officials, and industry colleagues who have played a pivotal role in making this inauguration a resounding success.